학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 30건 | 목록 1~10
Academic Journal
Morganti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Marra A; European Institute of Oncology IRCCS, Milan, Italy.; De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; Laster and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.; Giugliano F; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; INSERM U981-Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France.; Taurelli Salimbeni B; European Institute of Oncology IRCCS, Milan, Italy.; Berton Giachetti PPM; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Esposito A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Giordano A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.; Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Curigliano G; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Criscitiello C; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Academic Journal
Morganti S; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Marra A; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.; Ascione L; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Sajjadi E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Zagami P; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Giugliano F; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; INSERM U981 - Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France.; Taurelli Salimbeni B; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Berton Giachetti PPM; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Corti C; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; De Camilli E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Curigliano G; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Criscitiello C; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Pepe F; Department of Public Health, Federico II University of Naples, Naples, Italy.; Pescia C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy; School of Pathology, University of Milan, Milan, Italy.; Cursano G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Frascarelli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Mane E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Russo G; Department of Public Health, Federico II University of Naples, Naples, Italy.; Taurelli Salimbeni B; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Troncone G; Department of Public Health, Federico II University of Naples, Naples, Italy.; Guerini Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.; Fusco N; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Malapelle U; Department of Public Health, Federico II University of Naples, Naples, Italy.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
Academic Journal
Antonarelli G; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Taurelli Salimbeni B; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Marra A; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Esposito A; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Locatelli MA; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Trapani D; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Pescia C; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; Fusco N; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; Curigliano G; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy.; Criscitiello C; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it.
Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
Academic Journal
Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Taurelli Salimbeni B; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.; Santoro C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Antonarelli G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Taurelli Salimbeni B; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Clinical and Molecular Medicine, Oncology Unit, 'La Sapienza' University of Rome, Azienda Ospedaliera Sant'Andrea, Rome, Italy.; Ferraro E; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. giuseppe.curigliano@ieo.it.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy. giuseppe.curigliano@ieo.it.
Publisher: Springer Country of Publication: United States NLM ID: 8008541 Publication Model: Print Cited Medium: Print ISSN: 0927-3042 (Print) Linking ISSN: 09273042 NLM ISO Abbreviation: Cancer Treat Res Subsets: MEDLINE
Academic Journal
Uliano J; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Nicolò E; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Corvaja C; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Medicine, University of Udine, Udine, Italy.; Taurelli Salimbeni B; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Clinical and Molecular Medicine, Oncology Unit, 'La Sapienza' University of RomeAzienda Ospedaliera Sant'Andrea, Rome, Italy.; Trapani D; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Medical Oncology, Medical Oncology Dana Farber Cancer Institute, Boston, MA, USA.; Curigliano G; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Salimbeni, B. Taurelli
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어